Detailed View
DNTH - Dianthus Therapeutics, Inc.
Latest filing: 2025-12-31 | Reporting: gaap
Market Cap
3,371,400,960
Adj EBIT (TTM)
-177,933,000
Enterprise Value
2,971,419,960
Last Price
78
Earnings Yield
-5.99%
Return on Capital
-35.57%
Capital
500,190,000
1Y Price Chart
Last Price: $78.00
1Y Change: 265.68%
As of 2026-03-16 | 1Y Change: 265.68%
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 284,000 | -69,541,000 |
| 2025-09-30 | 10-Q | 2025 | 396,000 | -40,288,000 |
| 2025-06-30 | 10-Q | 2025 | 193,000 | -34,927,000 |
| 2025-03-31 | 10-Q | 2025 | 1,163,000 | -33,177,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 6,235,000 | -31,916,000 |
| 2024-09-30 | 10-Q | 2024 | 0 | -29,900,000 |
| 2024-06-30 | 10-Q | 2024 | 0 | -22,204,000 |
| 2024-03-31 | 10-Q | 2024 | 0 | -17,844,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.